37
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The orexigenic hormone acyl-ghrelin increases adult hippocampal neurogenesis and enhances pattern separation

      brief-report

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Highlights

          • Peripheral injections of acyl-ghrelin increase adult hippocampal neurogenesis.

          • Peripheral injections of acyl-ghrelin enhance pattern separation dependent memory.

          • Systemic administration of physiological levels of acyl-ghrelin has long-lasting memory benefits.

          Summary

          An important link exists between intact metabolic processes and normal cognitive functioning; however, the underlying mechanisms remain unknown. There is accumulating evidence that the gut hormone ghrelin, an orexigenic peptide that is elevated during calorie restriction (CR) and known primarily for stimulating growth hormone release, has important extra-hypothalamic functions, such as enhancing synaptic plasticity and hippocampal neurogenesis. The present study was designed to evaluate the long-term effects of elevating acyl-ghrelin levels, albeit within the physiological range, on the number of new adult born neurons in the dentate gyrus (DG) and performance on the Spontaneous Location Recognition (SLR) task, previously shown to be DG-dependent and sensitive to manipulations of plasticity mechanisms and cell proliferation. The results revealed that peripheral treatment of rats with acyl-ghrelin enhanced both adult hippocampal neurogenesis and performance on SLR when measured 8–10 days after the end of acyl-ghrelin treatment. Our data show that systemic administration of physiological levels of acyl-ghrelin can produce long-lasting improvements in spatial memory that persist following the end of treatment. As ghrelin is potentially involved in regulating the relationship between metabolic and cognitive dysfunction in ageing and neurodegenerative disease, elucidating the underlying mechanisms holds promise for identifying novel therapeutic targets and modifiable lifestyle factors that may have beneficial effects on the brain.

          Related collections

          Most cited references27

          • Record: found
          • Abstract: found
          • Article: not found

          A novel pathway regulates memory and plasticity via SIRT1 and miR-134

          The NAD-dependent deacetylase Sir2 was initially identified as a mediator of replicative lifespan in budding yeast and was subsequently shown to modulate longevity in worms and flies1,2. Its mammalian homologue, SIRT1, appears to have evolved complex systemic roles in cardiac function, DNA repair, and genomic stability. Recent studies suggest a functional relevance of SIRT1 in normal brain physiology and neurological disorders. However, it is unknown if SIRT1 plays a role in higher-order brain functions. We report that SIRT1 modulates synaptic plasticity and memory formation via a microRNA-mediated mechanism. Activation of SIRT1 enhances, while its loss-of-function impairs, synaptic plasticity. Surprisingly, these effects were mediated via post-transcriptional regulation of CREB expression by a brain-specific microRNA, miR-134. SIRT1 normally functions to limit expression of miR-134 via a repressor complex containing the transcription factor YY1, and unchecked miR-134 expression following SIRT1 deficiency results in the down-regulated expression of CREB and BDNF, thereby impairing synaptic plasticity. These findings demonstrate a novel role for SIRT1 in cognition and a previously unknown microRNA-based mechanism by which SIRT1 regulates these processes. Furthermore, these results describe a separate branch of SIRT1 signaling, in which SIRT1 has a direct role in regulating normal brain function in a manner that is disparate from its cell survival functions, demonstrating its value as a potential therapeutic target for the treatment of CNS disorders.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study.

            To evaluate any association between obesity in middle age, measured by body mass index and skinfold thickness, and risk of dementia later in life. Analysis of prospective data from a multiethnic population based cohort. Kaiser Permanente Northern California Medical Group, a healthcare delivery organisation. 10,276 men and women who underwent detailed health evaluations from 1964 to 1973 when they were aged 40-45 and who were still members of the health plan in 1994. Diagnosis of dementia from January 1994 to April 2003. Time to diagnosis was analysed with Cox proportional hazard models adjusted for age, sex, race, education, smoking, alcohol use, marital status, diabetes, hypertension, hyperlipidaemia, stroke, and ischaemic heart disease. Dementia was diagnosed in 713 (6.9%) participants. Obese people (body mass index > or = 30) had a 74% increased risk of dementia (hazard ratio 1.74, 95% confidence interval 1.34 to 2.26), while overweight people (body mass index 25.0-29.9) had a 35% greater risk of dementia (1.35, 1.14 to 1.60) compared with those of normal weight (body mass index 18.6-24.9). Compared with those in the lowest fifth, men and women in the highest fifth of the distribution of subscapular or tricep skinfold thickness had a 72% and 59% greater risk of dementia, respectively (1.72, 1.36 to 2.18, and 1.59, 1.24 to 2.04). Obesity in middle age increases the risk of future dementia independently of comorbid conditions.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              A receptor in pituitary and hypothalamus that functions in growth hormone release.

              Small synthetic molecules termed growth hormone secretagogues (GHSs) act on the pituitary gland and the hypothalamus to stimulate and amplify pulsatile growth hormone (GH) release. A heterotrimeric GTP-binding protein (G protein)-coupled receptor (GPC-R) of the pituitary and arcuate ventro-medial and infundibular hypothalamus of swine and humans was cloned and was shown to be the target of the GHSs. On the basis of its pharmacological and molecular characterization, this GPC-R defines a neuroendocrine pathway for the control of pulsatile GH release and supports the notion that the GHSs mimic an undiscovered hormone.
                Bookmark

                Author and article information

                Contributors
                Journal
                Psychoneuroendocrinology
                Psychoneuroendocrinology
                Psychoneuroendocrinology
                Pergamon Press
                0306-4530
                1873-3360
                1 January 2015
                January 2015
                : 51
                : 431-439
                Affiliations
                [a ]Department of Psychology, University of Cambridge, UK
                [b ]Behavioural and Clinical Neuroscience Institute, University of Cambridge, UK
                [c ]Molecular Neurobiology, Institute of Life Science, College of Medicine, Swansea University, UK
                Author notes
                [* ]Corresponding author at: Molecular Neurobiology, Institute of Life Science, College of Medicine, Swansea University, SA28PP, UK. Tel.: +44 01792 602209. jeff.s.davies@ 123456swansea.ac.uk
                [** ]Corresponding author at: Department of Psychology, Downing St, University of Cambridge, Cambridge CB23EB, UK. Tel.: +44 01223 7 65207. lms42@ 123456cam.ac.uk
                [1]

                These authors contributed equally to this work.

                Article
                S0306-4530(14)00399-0
                10.1016/j.psyneuen.2014.10.015
                4275579
                25462915
                37567626-f857-430b-a16c-2f28011f3214
                © 2014 The Authors

                This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/3.0/).

                History
                : 22 July 2014
                : 6 October 2014
                : 13 October 2014
                Categories
                Short Communication

                Endocrinology & Diabetes
                adult hippocampal neurogenesis,ghrelin,pattern separation
                Endocrinology & Diabetes
                adult hippocampal neurogenesis, ghrelin, pattern separation

                Comments

                Comment on this article